Insulin Endowed

John D. Rockefeller, Jr., gave his personal check for $150,000 to finance treatment of diabetes with insulin (TIME, April 21 and June 4). The purpose is to increase the number of free ward patients in American and Canadian hospitals who may be treated with insulin, and to teach practicing physicians the proper therapy of the extract.

The gift has no connection with the organized Rockefeller philanthropies, but will be distributed by Dr. Simon Flexner, Director of the Rockefeller Institute, to the following hospitals: University Hospital, Ann Arbor, Mich.; New England Deaconess Hospital, Boston; Johns Hopkins Hospital, Baltimore; Presbyterian Hospital, Chicago; Lakeside Hospital, Cleveland; University Hospital, Iowa City, la.; Royal Victoria Hospital, Montreal; Physiatric Institute, Morristown, N. J.; Touro Infirmary, New Orleans; Presbyterian Hospital, New York; Barnes Hospital, St. Louis; Hospital for Sick Children, Toronto General Hospital, Banting-Best Fund, University of Toronto, Toronto.

Dr. Flexner is an enthusiastic convert to the value of insulin, and declares there have been no failures in its beneficial effects. A committee of nine distinguished physicians, appointed by Dr. Banting, discoverer of the specific, and including Drs. Campbell and Fletcher, Toronto; Joslin and Fitz, Boston; Wilder, Rochester, Minn.; Geyelin, N. Y.; Woodyatt, Chicago; Allen and Sherrill,, Morristown, N. J., has just reported to the same effect, after nine months of rigorous clinical experiments. Insulin has in less than one year gained the complete approval of the medical profession. It is not, however, a permanent cure, and must be administered hypodermically at regular intervals, perhaps throughout the lifetime of the patient, in order to offset the lack of the normal internal secretion of the pancreas, which prevents diabetes.